Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Daily Archives: January 31, 2020

31 January 2020, Top 20 Shareholders

News & Announcements 2020By Richard Mollard January 31, 2020

200203_Top_Holders_Report

Recent Articles

200921_PharmAust Awarded FightMND Grant for Phase I Trial
September 21, 2020
14 September, Shareholder Update
September 14, 2020
Elanco not to Exercise Agreed Option
September 9, 2020
Monepantel Anti-Covid-19 Activity Confirmed
September 9, 2020

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

Retweet on Twitter PharmAust Retweeted

FinTech InShorts @fintechinshorts·

PharmAust: Awarded $881K grant for phase one monepantel trial
#FinTechInShorts #partnerships #funding #financeandeconomy #technology #bankingindustry #banking #financialmarkets
https://www.fintechinshorts.com/pharmaust-awarded-881k-grant-for-phase-one-monepantel-trial/?utm_cam

Reply on Twitter 1307915120060715008 Retweet on Twitter 13079151200607150082 Like on Twitter 13079151200607150084 Twitter 1307915120060715008

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions